Ashley Magargee
Biotech

Genentech's CEO on the next 50 years of the original biotech

Genentech CEO Ashley Magarge told Fierce how its AI collaborations, campus overhaul and late-stage pipeline are future-proofing the organization.
Darren Incorvaia Oct 1, 2026 8:00am
New approach methodologies in safety and toxicology testing Why proving repeatability is the next hurdle for widespread adop

NAMs: Why proving repeatability is the next hurdle for widespread adoption

Brought to you by Agilent Technologies
Pencil eraser erasing drawn human figure

Recruiters see ‘signs of recovery’ as biotech layoffs stay cool

Oct 1, 2026 9:00am
Boehringer Ingelheim booth at AACR 2026

Zealand slides as Boehringer-partnered obesity drug underwhelms

Oct 1, 2026 6:15am
Sanofi

Sanofi pays Regeneron $1B for 4 early-stage assets to ignite R&D

Oct 1, 2026 4:24am
x

Fierce Biotech Layoff Tracker 2026: Foghorn, BioMarin & more

Oct 1, 2026 10:30am
More News

Analysts unshaken by patient death in BMS lung fibrosis trial

Oct 1, 2026 10:22am

Foghorn lays off 40% of employees as Lilly collab collapses

Oct 1, 2026 8:36am

Lilly raises diabetes weight-loss bar with amylin-Zepbound combo

Sep 30, 2026 1:52pm

Beam sues rival startup, claims former scientist stole secrets

Sep 30, 2026 10:42am